A detailed history of Campbell & CO Investment Adviser LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 56,389 shares of GH stock, worth $2.39 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
56,389
Holding current value
$2.39 Million
% of portfolio
0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$20.2 - $38.11 $1.14 Million - $2.15 Million
56,389 New
56,389 $1.72 Million
Q3 2023

Nov 08, 2023

BUY
$25.8 - $39.97 $835,816 - $1.29 Million
32,396 New
32,396 $960,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.